| Dr Brian Wensel, PHARMD | |
|
809 University Blvd E, Tuscaloosa, AL 35401-2029 | |
| (205) 343-8509 | |
| Not Available |
| Full Name | Dr Brian Wensel |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 809 University Blvd E, Tuscaloosa, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760788616 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 16025 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian Wensel, PHARMD 809 University Blvd E, Tuscaloosa, AL 35401-2029 Ph: (205) 343-8509 | Dr Brian Wensel, PHARMD 809 University Blvd E, Tuscaloosa, AL 35401-2029 Ph: (205) 343-8509 |
News Archive
While the Unites States Congress is busy debating the high costs of health care reform, TreatmentReport.com aims to promote health system efficiency by making treatment information structured and transparent. On the site, people with health conditions can review and share treatment experiences with those researching their options.
Loyola Medicine has launched a research program to study a new treatment approach for stroke and spinal cord injury patients that involves electrically stimulating nerves.
In September, Children's Hospital Los Angeles physicians predicted it was a matter of when, and not if, Los Angeles children would become infected with Enterovirus EV-D68, commonly referred to as enterovirus D68. On Oct. 1, that day came. CHLA and public health officials announced that a young patient who had been hospitalized at CHLA with a respiratory illness and later experienced partial limb paralysis had tested positive for enterovirus D68.
Invuity, a leading developer of state-of-the-art illuminated surgical technology, today introduced its illuminated breast retractor system at the American College of Surgeons' 97th Annual Clinical Congress in San Francisco.
An experimental vaccine developed by researchers at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute targets overactive antigens in highly aggressive brain tumors and improves length of survival in newly diagnosed patients, according to new data that was presented in a poster session at the 47th Annual Meeting of the American Society of Clinical Oncology.
› Verified 5 days ago
Vito J Carruba, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3325 University Blvd E, Tuscaloosa, AL 35404 Phone: 205-556-3800 Fax: 205-556-0142 | |
Brittany Nicole Barnes, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3701 Loop Rd, Tuscaloosa, AL 35404 Phone: 205-554-2000 | |
Dr. Shelia Renee Miller, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4201 University Blvd E, Tuscaloosa, AL 35404 Phone: 205-553-9647 | |
Mr. Mike Pritchett, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4400 University Blvd E, Tuscaloosa, AL 35404 Phone: 205-553-6188 Fax: 205-553-6348 | |
Samantha Beams I, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3611 Rice Mine Rd Ne Lot 140, Tuscaloosa, AL 35406 Phone: 205-393-5876 | |
Mr. Jamie Floyd Sullivan, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3701 Loop Rd, Tuscaloosa, AL 35404 Phone: 205-554-2000 | |
Mr. Robert Shane Ballard, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4201 University Blvd E, Tuscaloosa, AL 35404 Phone: 205-553-9477 Fax: 205-553-9773 |